Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in ...

Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as being particularly good for the company. Last year, Ferring had record sales of ...

For more information, please contact Carine Julen Senior Manager, Corporate Communications & Public Affairs +41 76 301 0178 (mobile) [email protected] Ferring achieved total revenues of € ...